Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Camille Carroll

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Journal of Parkinson'S Disease|April 17, 2026
Transformation of Parkinson's care through SMART-PD (Self-Management, Remote monitoring and Timely review for Parkinson's Disease): Care pathway mapping with clinical expertsNicola Howe, Chikomborero C Mutepfa, Sara Pretorius, et al.
Journal of Parkinson'S Disease|April 25, 2022
Enhancing Trial Delivery in Parkinson's Disease: Qualitative Insights from PD STATAngie A Kehagia, Tracie K North, Jane Grose, et al.
Acta Neuropathologica|November 19, 2013
Accumulation of α-synuclein in the bowel of patients in the pre-clinical phase of Parkinson's diseaseDavid Hilton, Madeleine Stephens, Leanne Kirk, et al.
Glia|July 24, 2012
The role of insulin-like growth factors signaling in merlin-deficient human schwannomasSylwia Ammoun, M Caroline Schmid, Natalia Ristic, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 8, 2026
Placebo-controlled three-armed pilot trial of Escitalopram or Nortriptyline for depressive symptoms in Parkinson's disease (ADepT-PD)Anette Schrag, Andrew Embleton-Thirsk, Camille Carroll, et al.
Journal of Parkinson'S Disease|January 13, 2024
Addressing Comorbidities in People with Parkinson's Disease: Considerations From An Expert PanelCamille Carroll, Carl E Clarke, Donald Grosset, et al.
Trials|December 13, 2021
A report from the NIHR UK working group on remote trial delivery for the COVID-19 pandemic and beyondJane A H Masoli, Kim Down, Gary Nestor, et al.
Behavioral Sciences (Basel, Switzerland)|October 30, 2019
A Qualitative Study on the Impact of First Steps-A Peer-led Educational Intervention for People Newly Diagnosed with Parkinson's DiseaseAndrew Soundy, Johnny Collett, Sophie Lawrie, et al.
JAMA Neurology|October 31, 2022
Evaluation of Simvastatin as a Disease-Modifying Treatment for Patients With Parkinson Disease: A Randomized Clinical TrialKara N Stevens, Siobhan Creanor, Alison Jeffery, et al.
Neurodegenerative Disease Management|March 21, 2022
Opicapone in UK clinical practice: effectiveness, safety and cost analysis in patients with Parkinson's diseaseChristine Schofield, K Ray Chaudhuri, Camille Carroll, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Journal of Parkinson'S Disease|April 17, 2026
Transformation of Parkinson's care through SMART-PD (Self-Management, Remote monitoring and Timely review for Parkinson's Disease): Care pathway mapping with clinical expertsNicola Howe, Chikomborero C Mutepfa, Sara Pretorius, et al.
Journal of Parkinson'S Disease|April 25, 2022
Enhancing Trial Delivery in Parkinson's Disease: Qualitative Insights from PD STATAngie A Kehagia, Tracie K North, Jane Grose, et al.
Acta Neuropathologica|November 19, 2013
Accumulation of α-synuclein in the bowel of patients in the pre-clinical phase of Parkinson's diseaseDavid Hilton, Madeleine Stephens, Leanne Kirk, et al.
Glia|July 24, 2012
The role of insulin-like growth factors signaling in merlin-deficient human schwannomasSylwia Ammoun, M Caroline Schmid, Natalia Ristic, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 8, 2026
Placebo-controlled three-armed pilot trial of Escitalopram or Nortriptyline for depressive symptoms in Parkinson's disease (ADepT-PD)Anette Schrag, Andrew Embleton-Thirsk, Camille Carroll, et al.
Journal of Parkinson'S Disease|January 13, 2024
Addressing Comorbidities in People with Parkinson's Disease: Considerations From An Expert PanelCamille Carroll, Carl E Clarke, Donald Grosset, et al.
Trials|December 13, 2021
A report from the NIHR UK working group on remote trial delivery for the COVID-19 pandemic and beyondJane A H Masoli, Kim Down, Gary Nestor, et al.
Behavioral Sciences (Basel, Switzerland)|October 30, 2019
A Qualitative Study on the Impact of First Steps-A Peer-led Educational Intervention for People Newly Diagnosed with Parkinson's DiseaseAndrew Soundy, Johnny Collett, Sophie Lawrie, et al.
JAMA Neurology|October 31, 2022
Evaluation of Simvastatin as a Disease-Modifying Treatment for Patients With Parkinson Disease: A Randomized Clinical TrialKara N Stevens, Siobhan Creanor, Alison Jeffery, et al.
Neurodegenerative Disease Management|March 21, 2022
Opicapone in UK clinical practice: effectiveness, safety and cost analysis in patients with Parkinson's diseaseChristine Schofield, K Ray Chaudhuri, Camille Carroll, et al.
Pageof 6